Literature DB >> 8542753

Molecular genetics of clostridial neurotoxins.

N P Minton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8542753     DOI： 10.1007/978-3-642-85173-5_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  15 in total

1.  The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.

Authors:  Lance L Simpson; Andrew B Maksymowych; Hirokazu Kouguchi; Garrett Dubois; Roop S Bora; Suresh Joshi
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

2.  Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes.

Authors:  Clifford Shone; Heidi Agostini; Joanna Clancy; Mili Gu; Huei-Hsiung Yang; Yanfang Chu; Virginia Johnson; Makie Taal; Joanna McGlashan; John Brehm; Xiaomi Tong
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

3.  Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

Authors:  B Hallis; B A James; C C Shone
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

4.  The active site structure of tetanus neurotoxin resolved by multiple scattering analysis in X-Ray absorption spectroscopy.

Authors:  C Meneghini; S Morante
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

Review 5.  Bacterial protein toxins and cell vesicle trafficking.

Authors:  C Montecucco; E Papini; G Schiavo
Journal:  Experientia       Date:  1996-12-15

Review 6.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

7.  Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.

Authors:  S Kozaki; Y Kamata; T Nishiki; H Kakinuma; H Maruyama; H Takahashi; T Karasawa; K Yamakawa; S Nakamura
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 8.  Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

Authors:  R Pellizzari; O Rossetto; G Schiavo; C Montecucco
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

9.  Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Authors:  Jürgen Frevert; Dirk Dressler
Journal:  Biologics       Date:  2010-12-09

Review 10.  Emerging opportunities for serotypes of botulinum neurotoxins.

Authors:  Zhongxing Peng Chen; J Glenn Morris; Ramon L Rodriguez; Aparna Wagle Shukla; John Tapia-Núñez; Michael S Okun
Journal:  Toxins (Basel)       Date:  2012-11-07       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.